FirmAtlas
Company handbook · RVTY · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-17
RVTY · CIK 31791 · LATEST FILING: 10-Q JUL '26 · FILED AUG 11, 2026
REVVITY, INC.
$152.64
−2.07 (−1.34%)
Close, Oct 16, 2026 · 52-week $81–166
Last fiscal year
REVVITY, INC. reported revenue of $2.9B for the year ended Dec 28, 2025 (FY25), up 3.7% from FY24. Net income was $241M, operating cash flow $583M and free cash flow $509M. Source: 10-K filed Feb 24, 2026.
Market cap
$17.1B
P/E
72.2
EV/EBITDA
25.5x
P/B
2.4
Div yield
0.18%
ROIC
3.3%
Revenue 1Y
3.7%/yr
EPS 1Y
−5.9%/yr
Shares 1Y
−7%
Loading chart…
Median
Daily closes, split-adjusted · ratios at each fiscal year end
Company
CEOPrahlad R. Singh
HQWaltham, MA
AuditorDeloitte & Touche LLP
Employees11,000
Year endsDecember
Revenue by segment · FY25
Discovery Analytical Solutions50%
Diagnostics50%
Compounded growth & averages
10Y
5Y
3Y
TTM
Share price
11.3%
−2.1%
12.7%
62.4%
Upgrade to see 10 years
Share price: yearly compound rate of the traded close; the last column is the past year.
Where the cash went · FY24–FY25
$1.4B deployed
Capex
$160M
11.3%
Dividends
$67M
4.7%
Buybacks
$1.2B
84.0%
Operating cash flow over the period: $1.2B. Total debt changed by +$69M. R&D of $413M is already inside operating costs.
Growth engines
How much of the profit growth came from new investment, and how much from running the business better.
Upgrade to see 10 years
Financials
Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Dec 28, 2025 · change vs previous year
Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier
TTM = the last four quarters, to Jul '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.
Income
Revenue
2,755
2,856+3.7%
2,912
YoY
+3.7%
Operating income
347
357+2.9%
359
Operating margin
12.6%
12.5%−0.1 pp
—
EBITDA
775
762−1.6%
—
EBITDA margin
28.1%
26.7%−1.4 pp
—
Interest expense
96
92−4.3%
—
Interest coverage
8.05x
8.27x+0.22x
—
Net income
270
241−10.8%
238
YoY
−10.8%
Net margin
9.8%
8.4%−1.4 pp
—
EPS (diluted, $)
2.20
2.07−5.9%
2.11
YoY
−5.9%
Balance sheet
Total assets
12,392
12,168−1.8%
12,046
Cash & short-term investments
1,164
921−20.9%
—
Accounts receivable
632
745+17.8%
—
Inventory
368
379+3.2%
—
Net PP&E
482
479−0.6%
—
Other assets
9,746
9,644−1.0%
—
Total liabilities
4,726
4,918+4.1%
4,817
Accounts payable
167
185+10.7%
—
Total debt
3,151
3,220+2.2%
3,205
Other liabilities
1,407
1,513+7.5%
—
Shareholders’ equity
7,667
7,250−5.4%
7,229
Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.
Cash flow statement · as filed
Cash from operations
628
583−7.2%
628
Net income
270
241−10.8%
—
Depreciation & amortization
428
405−5.3%
—
Stock-based compensation
38
23−39.6%
—
Working capital & other
(108)
(86)n/m
—
Cash from investing
776
(17)−102.2%
—
Capex
(87)
(74)n/m
—
Investments bought
0
0n/m
—
Investments sold / matured
710
0−100.0%
—
Other investing
153
56−63.2%
—
Cash from financing
(1,128)
(858)n/m
—
Debt repaid
(711)
0n/m
—
Dividends
(34)
(33)n/m
—
Buybacks
(370)
(821)n/m
—
Other financing
(13)
(4)n/m
—
Net change in cash
250
(243)−197.3%
—
Free cash flow (OCF − capex)
542
509−6.0%
558
Where the cash went
Operating cash flow
628
583−7.2%
628
Reinvested in the business
87
74−15.1%
—
% of operating cash flow
13.8%
12.6%
Capex
87
74−15.1%
70
R&D (memo, already in costs)
197
216+9.7%
—
Free cash flow
542
509−6.0%
558
YoY
−6.0%
Returned to shareholders
404
854+111.3%
—
% of free cash flow
74.6%
167.6%
Dividends
34
33−4.8%
—
Buybacks
370
821+122.1%
—
Change in total debt
—
69
—
Cash left over
—
(275)
—
FCF conversion (FCF ÷ net income)
200.3%
211.2%+10.9 pp
—
Owner earnings
—
467
—
Owner earnings margin
—
16.3%
—
Buyback yield
2.7%
7.6%+4.8 pp
—
Returns & ratios
ROIC (all capital)
3.2%
3.3%+0.1 pp
—
ROIC (operating)
23.6%
23.3%−0.3 pp
—
Net debt / EBITDA
2.56x
3.02x+0.45x
—
Debt / equity
0.41x
0.44x+0.03x
—
Cash conversion cycle (days)
110
120+10 d
—
ROE
3.5%
3.3%−0.2 pp
—
ROA
2.2%
2.0%−0.2 pp
—
ROCE
3.0%
3.3%+0.3 pp
—
NOPAT
310
319+2.7%
—
Invested capital (operating)
1,315
1,418+7.9%
—
Invested capital (all)
9,653
9,549−1.1%
—
Reinvestment rate
—
32.4%
—
Debtor days
84
95+11 d
—
Inventory days
49
48−0 d
—
Days payable
22
24+2 d
—
Net debt is 3.0x EBITDA (FY25).
Income
Sep '25
Dec '25
Apr '26
Jul '26
Revenue
699
772
711
730
vs year-ago quarter
Gross profit
375
—
388
417
Gross margin
53.6%
—
54.5%
57.1%
Operating income
82
112
76
89
Net income
47
98
41
52
vs year-ago quarter
Net margin
6.7%
12.7%
5.7%
7.1%
EPS (diluted, $)
0.40
0.88
0.36
0.47
vs year-ago quarter
Balance sheet
Sep '25
Dec '25
Apr '26
Jul '26
Total assets
12,139
12,168
11,997
12,046
Cash & equivalents
933
921
861
1,024
Total debt
3,215
3,220
3,208
3,205
Shareholders’ equity
7,376
7,250
7,183
7,229
Cash flow
Sep '25
Dec '25
Apr '26
Jul '26
Operating cash flow
138
182
115
192
Capex
19
20
20
11
Free cash flow
120
162
95
181
vs year-ago quarter